Position in CTXR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,100
-$5,900 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 43 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTXR Over Time
Shares Held
Position Value (USD)
Derivatives in CTXR
reported options exposure · as of Dec 31, 2023CallValue
$314,155
CallShares
16,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $12,683,379 across 13 Biotechnology names. CTXR ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,205 | $3,245,525 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
9,439 | $2,274,514 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,330 | $1,654,110 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
20,646 | $1,615,961 | |
| 5 | TYRA |
Tyra Biosciences, Inc.
|
49,336 | $1,575,791 | |
| 6 | MRNA |
Moderna, Inc.
|
15,033 | $1,052,760 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
10,487 | $571,960 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
8,866 | $313,767 |
All Filings in CTXR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,100 | 20,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $18,000 | 20,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $15,540 | 20,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $24,800 | 20,000 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $31,800 | 20,000 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $14,900 | 10,000 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $40,000 | 10,000 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $100,200 | 200,000 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $87,600 | 150,000 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $89,700 | 100,000 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $314,155 | 415,000 | Call | Sole | 2024-01-24 | |
| 2023-12-31 | $75,700 | 100,000 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $283,860 | 415,000 | Call | Sole | 2023-10-13 | |
| 2023-09-30 | $68,400 | 100,000 | Shares | Sole | 2023-10-13 | |
| No filing history on record for this holder in this stock. | ||||||